Received Sep 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
slight reaction (fatigue) to Shingrix vaccine; This non-serious case was reported by a consumer and described the occurrence of fatigue in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Covid-19 vaccine. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fatigue (Verbatim: slight reaction (fatigue) to Shingrix vaccine). The outcome of the fatigue was resolved (duration 2 days). It was unknown if the reporter considered the fatigue to be related to Shingrix. It was unknown if the company considered the fatigue to be related to Shingrix. Additional Information: GSK Receipt Date: 25-AUG-2025 The reporter reported that he/she had lots of allergies and had reactions to the covid shots and a slight reaction (fatigue) to Shingrix vaccine. But in very case they only lasted 2 days at most. And with all of them the patient would do it over again without any hesitation. The actual diseases were far, far worse and their effects last much longer.